Skip to content

Profound Medical PROF CA — PP&E (Net)

Other geography segments

US
$491K+113%
FI
$164K

Similar metrics at other companies

Canopy Growth Corporation logo
CGCCA — PP&E (Net)
$233.21M-5.7%
Transcat logo
TRNSCA — PP&E (Net)
$4.83M-0.7%
Verra Mobility logo
VRRMCA — PP&E (Net)
$5.8M-45.3%
Kronos Worldwide logo
KROCA — PP&E (Net)
$73.6M+7.8%
Luxfer Holdings logo
LXFRCA — PP&E (Net)
$2.4M-11.1%
Alcoa logo
AACA — PP&E (Net)
$931M+3.1%

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's ca — pp&e (net).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's CA — PP&E (net)?
Profound Medical (PROF) reported CA — PP&E (net) of $27K in Q1 2026.
How has Profound Medical's CA — PP&E (net) changed year-over-year?
Profound Medical's CA — PP&E (net) decreased by 65.8% year-over-year, from $79K to $27K.
What does CA — PP&E (net) mean?
This metric measures the net book value of physical long-term assets, such as machinery, equipment, and facilities, utilized within the specified geographic segment. It indicates the level of infrastructure investment necessary to support the manufacturing and deployment of medical device systems.